Research Focus

Cardiovascular & Perioperative Medicine

Area of Research

Atrial fibrillation, especially evaluation of new technologies in the field of interventional therapy

• Swiss Atrial Fibrillation Cohort Study (Swiss-AF)
• Health consequences of the burden of atrial fibrillation (Swiss-AF Burden)
• Mechanisms of cognitive declin in the patients with atrial fibrillation (Swiss AF-Brain)
• Brain lesions and cognitive function in patients with versus without atrial fibrillation (Swiss-AF Control)
• Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry (SWISS-AF-PVI)
• BasEl ATriAl Fibrillation Cohort Study (BEAT-AF)
• Apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA)
• Prospective, observational Bern and Basel study on atrial fibrillation diagnosis in patients implanted with a cardiac monitor – the 2B-AF-PIC study
• Incidence of silent atrial fibrillation in patients with clinically silent brain ischemic lesions (SILENT2 – study)

National Collaborations

• Inselspital Bern – Prof. Tobias Reichlin, Prof. Nicolas Rodondi
• Stadtspital Triemli – Prof. Raban Jeger, Dr Andreas Müller
• Kantonsspital Baden (KSB) – Prof. Jürg Beer
• Kantonsspital St. Gallen (KSSG) – Prof. Peter Ammann
• Kantonsspital Luzern (LUKS) – Prof. Richard Kobza
• Bürgerspital Solothurn – Dr. Frank Peter Stephan
• Istituto Cardiocentro Ticino/EOC – Prof. Angelo Auricchio, Prof. Giulio Conte, PD Dr. Marcello di Valentino, Dr. Giorgio Moschovitis
• Hopital Universitaire de Geneve (HUG) – Prof. Dipen Shah
• Reha Rheinfelden – Prof. Leo Bonati
• Universität Basel – Prof. Andreas Monsch
• Universität Zürich – Prof. Matthias Schwenkglenks
• Medical Image Analysis Center (MIAC) – Dr. Tim Sinnecker
• Schiller AG – Ramun Schmid
• Roche AG – Dr. André Ziegler

International Collaborations

• Population Health Research Institute - Prof. David Conen
• Population Health Research Institute - Prof. Guillaume Paré
• Politecnico Milano – Prof. Valentina Corino

• Swiss Atrial Fibrillation Cohort Study (Swiss-AF)
• Health consequences of the burden of atrial fibrillation (Swiss-AF Burden)
• Mechanisms of cognitive decline in the patients with atrial fibrillation (Swiss AF-Brain)
• Brain lesions and cognitive function in patients with versus without atrial fibrillation (Swiss-AF Control)
• Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry (SWISS-AF-PVI)
• BasEl ATriAl Fibrillation Cohort Study (BEAT-AF)
• Apixaban for the reduction of thrombo-embolism in patients with device-detected sub-clinical atrial fibrillation (ARTESiA)
• Prospective, observational Bern and Basel study on atrial fibrillation diagnosis in patients implanted with a cardiac monitor – the 2B-AF-PIC study
• Incidence of silent atrial fibrillation in patients with clinically silent brain ischemic lesions (SILENT2 – study)